Jones, W.
67265  results:
Search for persons X
?
2

DOP17 Tofacitinib versus Vedolizumab Among Bio-naïve Patien..:

Gros, B ; Constantine-Cooke, N ; Kennedy, J...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i102-i103 , 2024
 
?
3

Update to RIFM fragrance ingredient safety assessment, isob..:

Api, A.M. ; Bartlett, A. ; Belsito, D....
Food and Chemical Toxicology.  192 (2024)  - p. 114779 , 2024
 
?
 
?
5

RIFM fragrance ingredient safety assessment, ethyl 2-methyl..:

Api, A.M. ; Bartlett, A. ; Belsito, D....
Food and Chemical Toxicology.  189 (2024)  - p. 114651 , 2024
 
?
6

Preparing Patients for Oral Immunotherapy (PPOINT): Interna..:

Mack, Douglas P. ; Dribin, Timothy E. ; Turner, Paul J....
Journal of Allergy and Clinical Immunology.  153 (2024)  6 - p. 1621-1633 , 2024
 
?
7

Update to RIFM fragrance ingredient safety assessment, 1-oc..:

Api, A.M. ; Belsito, D. ; Botelho, D....
Food and Chemical Toxicology.  183 (2024)  - p. 114278 , 2024
 
?
9

RIFM fragrance ingredient safety assessment, 1-propanol, 2-..:

Api, A.M. ; Bartlett, A. ; Belsito, D....
Food and Chemical Toxicology.  189 (2024)  - p. 114697 , 2024
 
?
11

RIFM fragrance ingredient safety assessment, 4-methyl-4-phe..:

Api, A.M. ; Belsito, D. ; Botelho, D....
Food and Chemical Toxicology.  183 (2024)  - p. 114388 , 2024
 
?
12

Update to RIFM fragrance ingredient safety assessment, α-pr..:

Api, A.M. ; Bartlett, A. ; Belsito, D....
Food and Chemical Toxicology.  192 (2024)  - p. 114837 , 2024
 
1-15